Literature DB >> 26386012

Adverse Effects of Diabetes Mellitus on the Skeleton of Aging Mice.

Sergio Portal-Núñez1, Juan Antonio Ardura1, Daniel Lozano2, Oskarina Hernández Bolívar3, Ana López-Herradón1, Irene Gutiérrez-Rojas4, Alexander Proctor5, Bram van der Eerden6, Marijke Schreuders-Koedam6, Johannes van Leeuwen6, María José Alcaraz7, Francisca Mulero8, Mónica de la Fuente3, Pedro Esbrit1.   

Abstract

In the present study, the possibility that a diabetic (DM) status might worsen age-related bone deterioration was explored in mice. Male CD-1 mice aged 2 (young control group) or 16 months, nondiabetic or made diabetic by streptozotocin injections, were used. DM induced a decrease in bone volume, trabecular number, and eroded surface, and in mineral apposition and bone formation rates, but an increased trabecular separation, in L1-L3 vertebrae of aged mice. Three-point bending and reference point indentation tests showed slight changes pointing to increased frailty and brittleness in the mouse tibia of diabetic old mice. DM was related to a decreased expression of both vascular endothelial growth factor and its receptor 2, which paralleled that of femoral vasculature, and increased expression of the pro-adipogenic gene peroxisome proliferator-activated receptor γ and adipocyte number, without affecting β-catenin pathway in old mouse bone. Concomitant DM in old mice failed to affect total glutathione levels or activity of main anti-oxidative stress enzymes, although xanthine oxidase was slightly increased, in the bone marrow, but increased the senescence marker caveolin-1 gene. In conclusion, DM worsens bone alterations of aged mice, related to decreased bone turnover and bone vasculature and increased senescence, independently of the anti-oxidative stress machinery.
© The Author 2015. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Aging; Diabetes mellitus; Mice; Osteoporosis

Mesh:

Year:  2015        PMID: 26386012     DOI: 10.1093/gerona/glv160

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  4 in total

Review 1.  Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Authors:  Robert J Pignolo; Rebekah M Samsonraj; Susan F Law; Haitao Wang; Abhishek Chandra
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

2.  Exogenous melatonin prevents type 1 diabetes mellitus-induced bone loss, probably by inhibiting senescence.

Authors:  Z Gong; W Da; Y Tian; R Zhao; S Qiu; Q Wu; K Wen; L Shen; R Zhou; L Tao; Y Zhu
Journal:  Osteoporos Int       Date:  2021-09-14       Impact factor: 5.071

Review 3.  The role of vasculature in bone development, regeneration and proper systemic functioning.

Authors:  Joanna Filipowska; Krzysztof A Tomaszewski; Łukasz Niedźwiedzki; Jerzy A Walocha; Tadeusz Niedźwiedzki
Journal:  Angiogenesis       Date:  2017-02-13       Impact factor: 9.596

4.  Inhibition of aberrant Hif1α activation delays intervertebral disc degeneration in adult mice.

Authors:  Zuqiang Wang; Hangang Chen; Qiaoyan Tan; Junlan Huang; Siru Zhou; Fengtao Luo; Dali Zhang; Jing Yang; Can Li; Bo Chen; Xianding Sun; Liang Kuang; Wanling Jiang; Zhenhong Ni; Quan Wang; Shuai Chen; Xiaolan Du; Di Chen; Chuxia Deng; Liangjun Yin; Lin Chen; Yangli Xie
Journal:  Bone Res       Date:  2022-01-05       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.